approved EB-2 (NIW)

Graduate Research Assistant

Computer Engineering · Iran · 2025-09-08

Processing Time
606 days
Decision Date
2025-09-08
Location
Kansas
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue his research at the intersection of quantum chemistry simulations, machine learning, and big data analytics to accelerate drug discovery and personalize medical treatments. His work focuses on creating precise molecular models that shorten the pharmaceutical development cycle and tailor therapies to individual genetic profiles. Additionally, he intends to apply advanced forecasting models to support environmental sustainability and resource management.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor was found to have national importance due to its role in accelerating drug discovery and advancing environmental sustainability.

2 Well-positioned to Advance the Endeavor Met

The petitioner's academic publications, citation count, and peer review contributions demonstrate he is well-positioned to succeed.

3 Waiver Benefit to the US Met

On balance, the U.S. benefits from waiving the job offer requirement to support innovations in computational healthcare and resource management.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of two peer-reviewed journal articles, one conference paper, and one book chapter, which accumulated 41 citations. His expertise was further evidenced by his experience as a peer reviewer for a scientific journal. The case successfully satisfied all three Dhanasar prongs by demonstrating the national importance of AI-driven drug discovery and the petitioner's strong positioning in the field.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Conference Presentations
Judging Experience
Original Contributions

Similar Cases

Machine Learning Engineer

Biotechnology · China

WeGreened EB-2 (NIW) approved
Massachusetts 22 days 2025-04-22
The petitioner proposes to develop advanced machine learning methods, cheminformatics tools, and modeling techniques to accurately predict molecular and chemical reaction properties. This work aims to accelerate the discovery of new molecules and streamline screening processes for pharmaceuticals, cosmetics, biofuels, and industrial dyes. The endeavor focuses on integrating predictive algorithms with cheminformatics models to assess novel molecules with high speed and accuracy.

Scientist

Biotechnology · India

WeGreened EB-2 (NIW) approved
California 4 days 2025-08-08
The petitioner proposes to develop and apply advanced machine learning and computational chemistry methods to predict molecular properties with high accuracy. This work focuses on the targeted design of novel molecules to accelerate drug discovery and reduce the high costs and failure rates associated with therapeutic development.

Others

Research and Development · China

WeGreened EB-2 (NIW) approved
285 days 2025-02-02
The petitioner proposes to develop state-of-the-art machine learning methods for multiscale computational chemistry modeling to support the design and discovery of advanced materials and therapeutics. This work focuses on creating peptide, antibody, and small molecule therapies for treating cancer, obesity, and autoimmune diseases.

Research Assistant

Pharmaceuticals · China

WeGreened EB-2 (NIW) approved
California 426 days 2025-01-08
The petitioner proposes to continue research in pharmaceutical chemistry with a focus on drug discovery optimization and the development of advanced computational techniques. This work involves identifying new therapeutics for human diseases and creating computational methods that offer significant advantages over conventional drug discovery approaches. The intended impact is to reduce the economic and social costs of disease while improving global public health.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-09-08.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 606 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist